Laserfiche WebLink
PUBLIC NOTICE <br /> Notice of this meeting was sent to property owners and tenants/occupants within <br /> 1 ,000 feet of the site as shown in Exhibit G. At the time of report publication, staff has not <br /> received any public comments beyond those responded to in the Final IS/MND in Exhibit D. <br /> Public comments received after publication of this report will be forwarded to the Commission. <br /> ENVIRONMENTAL ASSESSMENT <br /> A draft Mitigated Negative Declaration has been prepared for the proposed project. The <br /> analysis in the Initial Study concludes all the project-related environmental impacts are <br /> mitigated, with the mitigation measures incorporated in the project's design or required by <br /> conditions of approval, and there would be no significant or unmitigated environmental <br /> impacts. Staff, therefore, believes the Mitigated Negative Declaration can be issued in <br /> conformance with CEQA. If the Planning Commission concurs with this environmental <br /> assessment, the Planning Commission should recommend the City Council adopt the <br /> Mitigated Negative Declaration prior to acting on the project. <br /> SUMMARY/CONCLUSION <br /> Staff finds the site plan to be functional, with efficient on-site circulation, adequate provisions <br /> for parking, and well-designed landscaped features. Building 1 and future proposed structures <br /> are positioned to create a positive visual presence on Stoneridge Mall Road and Springdale <br /> Avenue. The design of Building 1 and future proposed structures are attractive, and the <br /> architectural style, colors, and materials will complement the surrounding development. <br /> Affected street intersections will be mitigated to provide for efficient flow and to maintain <br /> acceptable levels of service. <br /> Primary Author Eric Luchini, Senior Planner 925-931-5612 or eluchini�cityofpleasantonca.gov <br /> Reviewed/Approved By. <br /> Melinda Denis, Planning and Permit Center Manager <br /> Ellen Clark, Director of Community Development <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 32 of 32 <br />impacts can be <br /> mitis ated. <br /> Redevelopment of an underperforming retail Loss of retail space; however, the proposed <br /> site. 10x Genomics project would significantly <br /> exceed the sales tax produced by the prior <br /> retail center <br /> Retention and expansion of an existing ' Significant portion of subject site could <br /> business operating within the City, including remain undeveloped for a significant period <br /> preservation of high-wage jobs, and of time. <br /> increased sales tax revenue. <br /> New buildings and landscaping would <br /> upgrade and enhance the visual quality of the <br /> site and streetscape. <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 31 of 32 <br />erty. A <br /> development agreement is a commitment between the City and a property owner or developer <br /> to proceed with a specific development in accordance with the terms of an agreement that <br /> describes what land use and related processes shall apply to the application. In essence, a <br /> development agreement locks in the laws in existence at the time of entering into the <br /> agreement and the City agrees not to change its planning or zoning laws applicable to the <br /> specific development project for a specified period. Therefore, future land use decisions <br /> regarding such a development project would not be based on then current planning and zoning <br /> law, but rather they would be based on the laws in existence at the time the development <br /> agreement was executed. The developer gains certainty, through the development agreement, <br /> of the continuity of regulations in force at the time of entering into the development agreement <br /> and prior to a commitment of a substantial investment for project improvements. In exchange, <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 30 of 32 <br />and primary)). <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 19 of 32 <br /><br />